Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Peter Kabos

Concepts (428)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
60
2026
2452
6.130
 Why?
Receptors, Estrogen
24
2026
457
3.120
 Why?
Estrogen Receptor alpha
6
2025
161
1.480
 Why?
Receptors, Progesterone
13
2025
356
1.410
 Why?
Brain Neoplasms
16
2026
1318
1.130
 Why?
Estradiol
4
2025
533
1.010
 Why?
Aging, Premature
1
2025
16
0.920
 Why?
High-Intensity Interval Training
1
2025
46
0.880
 Why?
Doxorubicin
4
2025
397
0.860
 Why?
Antibiotics, Antineoplastic
1
2025
139
0.850
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2025
1953
0.810
 Why?
Estrogens
8
2026
380
0.800
 Why?
Keratin-5
6
2022
48
0.790
 Why?
Triple Negative Breast Neoplasms
6
2023
215
0.760
 Why?
Breast Neoplasms, Male
3
2018
29
0.740
 Why?
Stem Cells
8
2006
626
0.710
 Why?
Biomarkers, Tumor
7
2022
1313
0.710
 Why?
Tetrahydronaphthalenes
1
2021
31
0.660
 Why?
Chromatin
1
2025
561
0.660
 Why?
Antineoplastic Agents, Hormonal
7
2025
194
0.660
 Why?
MCF-7 Cells
5
2025
135
0.640
 Why?
Neoplasm Metastasis
4
2020
688
0.640
 Why?
Immunoprecipitation
4
2020
151
0.640
 Why?
Drug Resistance, Neoplasm
5
2025
881
0.620
 Why?
Neoplastic Cells, Circulating
1
2020
81
0.610
 Why?
Neurons
9
2026
1640
0.610
 Why?
Brain Edema
2
2023
62
0.610
 Why?
Benzodiazepines
1
2021
167
0.600
 Why?
Female
62
2026
78271
0.580
 Why?
Radiosurgery
3
2023
400
0.570
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
61
0.570
 Why?
Epithelial-Mesenchymal Transition
1
2020
219
0.560
 Why?
Artifacts
2
2016
139
0.560
 Why?
Leukocytes, Mononuclear
2
2020
573
0.560
 Why?
Binding Sites
2
2025
1329
0.550
 Why?
Gene Expression Regulation, Neoplastic
11
2025
1455
0.520
 Why?
Gene Expression Profiling
7
2020
1782
0.520
 Why?
Fanconi Anemia Complementation Group N Protein
1
2017
4
0.510
 Why?
Polyadenylation
1
2017
41
0.510
 Why?
Protein Kinase Inhibitors
7
2025
969
0.510
 Why?
Neoplastic Stem Cells
7
2020
412
0.500
 Why?
High-Throughput Nucleotide Sequencing
4
2019
549
0.500
 Why?
Organoplatinum Compounds
1
2016
66
0.500
 Why?
Carcinogenesis
2
2020
229
0.490
 Why?
Cancer-Associated Fibroblasts
1
2016
23
0.490
 Why?
Piperazines
5
2025
381
0.480
 Why?
Humans
75
2026
144759
0.470
 Why?
Cell Line, Tumor
17
2026
3540
0.470
 Why?
Pyridines
6
2025
605
0.460
 Why?
Fluorouracil
1
2016
235
0.460
 Why?
CD146 Antigen
3
2021
40
0.450
 Why?
Mitochondrial Proteins
1
2017
262
0.450
 Why?
Microscopy, Electron, Scanning Transmission
1
2014
3
0.440
 Why?
Thrombocytopenia
1
2016
205
0.430
 Why?
Microwaves
1
2014
31
0.430
 Why?
Maytansine
1
2014
18
0.430
 Why?
Microscopy
1
2014
156
0.390
 Why?
Trastuzumab
5
2023
118
0.370
 Why?
Receptors, Cytoplasmic and Nuclear
1
2014
209
0.370
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2026
58
0.370
 Why?
Neoplasms, Hormone-Dependent
1
2012
41
0.370
 Why?
Progestins
6
2025
87
0.360
 Why?
Tamoxifen
5
2025
217
0.360
 Why?
Antineoplastic Agents
4
2023
2194
0.360
 Why?
RNA-Binding Proteins
1
2016
462
0.360
 Why?
Analgesics, Opioid
1
2021
1143
0.360
 Why?
Tumor Microenvironment
4
2021
732
0.360
 Why?
RNA Polymerase III
2
2025
34
0.350
 Why?
Homeodomain Proteins
5
2018
523
0.350
 Why?
MicroRNAs
5
2016
701
0.350
 Why?
Chemotherapy, Adjuvant
5
2023
421
0.340
 Why?
Repressor Proteins
2
2025
437
0.330
 Why?
RNA
2
2016
940
0.330
 Why?
Cancer Survivors
2
2026
327
0.330
 Why?
Neoplasm Recurrence, Local
5
2021
1137
0.320
 Why?
Mutation
3
2021
4089
0.320
 Why?
Neoadjuvant Therapy
3
2021
462
0.310
 Why?
Image Processing, Computer-Assisted
1
2014
780
0.310
 Why?
Antibodies, Monoclonal, Humanized
2
2021
985
0.300
 Why?
Tumor Cells, Cultured
7
2020
919
0.300
 Why?
Astrocytes
6
2026
222
0.290
 Why?
Pyrimidines
3
2018
532
0.290
 Why?
Middle Aged
20
2026
35875
0.290
 Why?
Liver Neoplasms
1
2015
780
0.290
 Why?
Neoplasm Staging
5
2026
1462
0.290
 Why?
Carcinoma, Ductal, Breast
2
2020
88
0.280
 Why?
Hydrocephalus
3
2023
111
0.280
 Why?
Colorectal Neoplasms
1
2016
845
0.280
 Why?
Signal Transduction
6
2026
5226
0.280
 Why?
Prognosis
7
2021
4282
0.280
 Why?
Adenocarcinoma
1
2015
928
0.270
 Why?
Bone Marrow Cells
2
2014
320
0.260
 Why?
Aged
17
2025
25913
0.240
 Why?
Neural Cell Adhesion Molecules
1
2026
38
0.240
 Why?
Helix-Loop-Helix Motifs
2
2002
12
0.240
 Why?
Adult
20
2026
40449
0.240
 Why?
Necrosis
2
2019
244
0.230
 Why?
Fibroblast Growth Factor 2
1
2026
93
0.230
 Why?
Aged, 80 and over
7
2025
8265
0.230
 Why?
Cluster Analysis
4
2019
521
0.230
 Why?
Chondroitin Sulfate Proteoglycans
2
2006
10
0.230
 Why?
Fatty Acid Synthase, Type I
1
2025
11
0.220
 Why?
Sequence Analysis, RNA
2
2019
442
0.220
 Why?
STAT1 Transcription Factor
1
2025
68
0.220
 Why?
Neuroglia
2
2003
172
0.220
 Why?
Protein Binding
2
2025
2273
0.220
 Why?
Weight Reduction Programs
1
2026
136
0.220
 Why?
Neoplasm Grading
2
2017
307
0.220
 Why?
RNA, Transfer
1
2025
144
0.210
 Why?
Mice, Inbred NOD
5
2021
610
0.210
 Why?
Genetic Therapy
2
2003
313
0.210
 Why?
Animals
28
2026
38058
0.210
 Why?
Aminopyridines
2
2025
127
0.210
 Why?
Carbolines
1
2024
35
0.210
 Why?
Disease-Free Survival
4
2024
769
0.200
 Why?
Aromatase Inhibitors
2
2021
75
0.200
 Why?
Triazines
1
2024
49
0.200
 Why?
Mice
20
2026
18339
0.200
 Why?
Progesterone
3
2014
255
0.200
 Why?
Obesity
3
2026
3077
0.200
 Why?
Benzimidazoles
2
2025
190
0.200
 Why?
Morpholines
1
2024
128
0.200
 Why?
Promoter Regions, Genetic
3
2025
1257
0.190
 Why?
Extracellular Matrix Proteins
1
2004
158
0.190
 Why?
Keratin-17
1
2022
4
0.190
 Why?
Aquaporin 4
2
2023
98
0.190
 Why?
Triglycerides
1
2025
520
0.190
 Why?
Nerve Regeneration
1
2002
56
0.190
 Why?
Tumor Suppressor Proteins
2
2015
321
0.180
 Why?
Mice, SCID
4
2020
369
0.180
 Why?
Stromal Cells
2
2020
124
0.180
 Why?
Down-Regulation
4
2015
627
0.180
 Why?
Glioma
5
2006
425
0.180
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2025
108
0.180
 Why?
Cell-Free Nucleic Acids
1
2022
33
0.180
 Why?
Immunoconjugates
1
2023
132
0.180
 Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.180
 Why?
Neoplasm Invasiveness
3
2020
508
0.180
 Why?
Cyclins
1
2002
84
0.170
 Why?
Lipid Metabolism
1
2025
527
0.170
 Why?
Tumor Suppressor Protein p53
2
2015
529
0.170
 Why?
Medicare
3
2023
886
0.170
 Why?
Overweight
1
2026
609
0.170
 Why?
Transcription, Genetic
2
2025
1496
0.170
 Why?
Insulin Receptor Substrate Proteins
1
2020
55
0.160
 Why?
Brain
3
2026
2933
0.160
 Why?
Gene Regulatory Networks
2
2014
318
0.160
 Why?
Cell Adhesion Molecules
1
2021
178
0.160
 Why?
Disease Progression
5
2026
2847
0.160
 Why?
gamma-Aminobutyric Acid
1
2002
192
0.160
 Why?
Cancer Care Facilities
1
2020
48
0.160
 Why?
Meningeal Carcinomatosis
1
2020
7
0.160
 Why?
Antigens, Neoplasm
1
2021
271
0.160
 Why?
RNA, Messenger
3
2019
2832
0.160
 Why?
Hyaluronan Receptors
4
2014
102
0.150
 Why?
Retrospective Studies
6
2025
17066
0.150
 Why?
SEER Program
1
2021
224
0.150
 Why?
Cell Proliferation
6
2025
2496
0.150
 Why?
Carcinoma, Lobular
1
2020
56
0.150
 Why?
Antineoplastic Agents, Immunological
2
2019
199
0.150
 Why?
Gene Library
2
2019
126
0.150
 Why?
Collagen
2
2020
456
0.150
 Why?
Transcriptome
2
2019
1045
0.150
 Why?
Lymphatic Metastasis
2
2017
333
0.150
 Why?
ErbB Receptors
2
2020
627
0.150
 Why?
Treatment Outcome
6
2025
11679
0.140
 Why?
Paclitaxel
1
2020
255
0.140
 Why?
beta Catenin
1
2020
252
0.130
 Why?
Heterografts
4
2020
143
0.130
 Why?
Xenograft Model Antitumor Assays
4
2017
928
0.130
 Why?
3' Untranslated Regions
1
2017
152
0.120
 Why?
Feasibility Studies
2
2026
1095
0.120
 Why?
Pyrroles
1
2017
217
0.120
 Why?
Quinolines
3
2025
193
0.120
 Why?
Receptors, Androgen
1
2017
153
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
99
0.120
 Why?
Genital Neoplasms, Female
1
2017
99
0.120
 Why?
Gene Expression
2
2016
1490
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
983
0.120
 Why?
Neoplasms, Second Primary
1
2016
100
0.110
 Why?
Ovary
1
2017
228
0.110
 Why?
Single-Cell Analysis
1
2019
358
0.110
 Why?
Combined Modality Therapy
2
2019
1266
0.110
 Why?
Ribosomal Proteins
1
2015
91
0.110
 Why?
Proto-Oncogene Proteins c-akt
1
2017
436
0.110
 Why?
Paracrine Communication
1
2015
67
0.110
 Why?
DNA Primers
1
2016
512
0.110
 Why?
Isoquinolines
2
2025
44
0.110
 Why?
Cell Movement
4
2026
965
0.110
 Why?
Azetidines
2
2025
45
0.110
 Why?
Risk Reduction Behavior
1
2016
226
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
STAT5 Transcription Factor
1
2014
52
0.110
 Why?
Reactive Oxygen Species
1
2017
621
0.110
 Why?
Azepines
1
2015
107
0.110
 Why?
Pyrazoles
1
2018
509
0.110
 Why?
Odds Ratio
1
2017
1075
0.100
 Why?
Fibroblasts
1
2020
1034
0.100
 Why?
Receptors, Steroid
1
2014
45
0.100
 Why?
Microscopy, Atomic Force
1
2014
134
0.100
 Why?
Apoptosis
4
2017
2430
0.100
 Why?
Peptides
1
2020
995
0.100
 Why?
Clinical Decision-Making
1
2017
359
0.100
 Why?
Software
2
2019
690
0.100
 Why?
Quinazolines
2
2025
266
0.100
 Why?
CD24 Antigen
1
2012
18
0.090
 Why?
DNA-Binding Proteins
2
2015
1499
0.090
 Why?
Sensitivity and Specificity
2
2016
1985
0.090
 Why?
Retinoids
1
2012
33
0.090
 Why?
Anthracyclines
2
2023
47
0.090
 Why?
RNA Interference
1
2014
476
0.090
 Why?
Opioid-Related Disorders
1
2021
600
0.090
 Why?
Disease Models, Animal
4
2017
4557
0.090
 Why?
Taxoids
2
2023
116
0.090
 Why?
Cell Differentiation
4
2004
2050
0.090
 Why?
Comorbidity
1
2017
1658
0.090
 Why?
Clinical Trials as Topic
1
2017
1053
0.090
 Why?
Genome, Human
1
2014
422
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
173
0.090
 Why?
Small Molecule Libraries
1
2012
111
0.080
 Why?
Drug Discovery
1
2012
155
0.080
 Why?
Tumor Burden
1
2012
319
0.080
 Why?
Male
8
2018
72315
0.080
 Why?
United States
4
2023
15966
0.080
 Why?
Rats
5
2017
5597
0.080
 Why?
Mitochondria
1
2017
984
0.080
 Why?
Logistic Models
1
2016
2117
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
758
0.080
 Why?
Estrogen Antagonists
1
2010
48
0.080
 Why?
Dendritic Cells
2
2004
499
0.080
 Why?
Nuclear Proteins
1
2015
748
0.080
 Why?
Time Factors
3
2020
7173
0.080
 Why?
Lung Neoplasms
1
2023
2637
0.080
 Why?
Transforming Growth Factor beta
1
2012
479
0.080
 Why?
BRCA2 Protein
1
2009
67
0.070
 Why?
Pregnancy Complications, Neoplastic
1
2009
63
0.070
 Why?
Administration, Oral
2
2024
847
0.070
 Why?
Thrombophilia
1
2009
88
0.070
 Why?
Cell Culture Techniques
2
2020
375
0.070
 Why?
Receptors, CXCR4
2
2006
91
0.070
 Why?
Practice Patterns, Physicians'
1
2017
1356
0.070
 Why?
Cells, Cultured
3
2006
4154
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2002
1217
0.070
 Why?
Stem Cell Transplantation
3
2004
191
0.070
 Why?
Proteoglycans
2
2006
110
0.060
 Why?
Genetic Predisposition to Disease
1
2016
2363
0.060
 Why?
Immunohistochemistry
2
2017
1716
0.060
 Why?
Radiotherapy, Adjuvant
2
2018
222
0.060
 Why?
Rats, Sprague-Dawley
2
2002
2527
0.060
 Why?
Aurora Kinase A
2
2018
62
0.060
 Why?
Algorithms
1
2014
1837
0.060
 Why?
Risk Factors
2
2020
10779
0.060
 Why?
Drug Delivery Systems
1
2010
380
0.060
 Why?
Proof of Concept Study
1
2026
85
0.060
 Why?
Biopsy
2
2020
1075
0.060
 Why?
Severity of Illness Index
1
2014
2925
0.060
 Why?
Transcription Factor TFIIIB
1
2025
5
0.060
 Why?
TATA-Binding Protein Associated Factors
1
2025
22
0.060
 Why?
Nervous System
1
2006
70
0.060
 Why?
Rats, Inbred F344
2
2003
268
0.060
 Why?
Cyclin-Dependent Kinase 4
1
2025
53
0.060
 Why?
Mass Spectrometry
2
2020
750
0.060
 Why?
Cyclin-Dependent Kinase 6
1
2025
49
0.060
 Why?
Neoplasm Transplantation
2
2016
251
0.060
 Why?
Tomography, X-Ray Computed
1
2015
2730
0.050
 Why?
Infant, Premature, Diseases
1
2006
111
0.050
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.050
 Why?
Aggrecans
1
2004
15
0.050
 Why?
Purines
1
2025
187
0.050
 Why?
Lectins, C-Type
1
2004
62
0.050
 Why?
Cyclophosphamide
2
2018
266
0.050
 Why?
Maximum Tolerated Dose
1
2024
212
0.050
 Why?
Cell Line
2
2014
2882
0.050
 Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
8
0.050
 Why?
Mastectomy, Segmental
2
2017
108
0.050
 Why?
Adipose Tissue
2
2018
652
0.050
 Why?
Aromatase
1
2023
32
0.050
 Why?
Inhibitor of Differentiation Protein 2
1
2002
5
0.050
 Why?
Follow-Up Studies
2
2025
5408
0.050
 Why?
Bridged-Ring Compounds
1
2023
31
0.050
 Why?
Inhibitor of Differentiation Protein 1
1
2002
8
0.050
 Why?
Glioblastoma
2
2006
353
0.050
 Why?
Camptothecin
1
2023
140
0.050
 Why?
Edema
1
2023
124
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
58
0.050
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
9
0.050
 Why?
Pyramidal Tracts
1
2002
30
0.050
 Why?
Sciatic Nerve
1
2002
59
0.050
 Why?
Neurites
1
2002
50
0.050
 Why?
Mice, Inbred C57BL
5
2004
5992
0.050
 Why?
Vimentin
1
2022
54
0.050
 Why?
Gonadotropin-Releasing Hormone
1
2024
212
0.050
 Why?
Transcription Factor HES-1
1
2002
5
0.050
 Why?
Interleukin-12
1
2002
117
0.050
 Why?
Phenotype
1
2010
3162
0.040
 Why?
Blotting, Western
1
2004
1187
0.040
 Why?
Frontal Lobe
1
2002
160
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
112
0.040
 Why?
Oligonucleotides, Antisense
1
2002
116
0.040
 Why?
Fibroblast Growth Factors
1
2002
188
0.040
 Why?
Mice, Inbred BALB C
1
2004
1253
0.040
 Why?
Ependymoma
1
2003
176
0.040
 Why?
Protein-Lysine 6-Oxidase
1
2020
14
0.040
 Why?
Cerebral Cortex
1
2004
464
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
52
0.040
 Why?
TOR Serine-Threonine Kinases
1
2024
449
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Nucleosomes
1
2022
165
0.040
 Why?
Weight Loss
1
2026
836
0.040
 Why?
Nervous System Diseases
1
2003
284
0.040
 Why?
Neoplasms
1
2015
2875
0.040
 Why?
Membrane Glycoproteins
1
2002
496
0.040
 Why?
Animals, Newborn
1
2002
902
0.040
 Why?
Adherens Junctions
1
2020
24
0.040
 Why?
Dose-Response Relationship, Drug
1
2024
2027
0.040
 Why?
Gene Knockout Techniques
1
2020
116
0.040
 Why?
Protein Interaction Mapping
1
2020
104
0.040
 Why?
Patient Acceptance of Health Care
1
2026
885
0.040
 Why?
Interferon-gamma
1
2002
784
0.040
 Why?
Kaplan-Meier Estimate
1
2021
965
0.040
 Why?
Mice, Nude
2
2015
682
0.040
 Why?
beta-Galactosidase
3
2002
77
0.040
 Why?
DNA, Complementary
1
2019
276
0.040
 Why?
Loss of Function Mutation
1
2018
46
0.030
 Why?
Maintenance Chemotherapy
1
2018
42
0.030
 Why?
Cadherins
1
2020
201
0.030
 Why?
Immunotherapy
1
2003
653
0.030
 Why?
Nausea
1
2018
111
0.030
 Why?
Wnt Signaling Pathway
1
2020
210
0.030
 Why?
Breast
1
2018
158
0.030
 Why?
Phenylthiohydantoin
1
2017
44
0.030
 Why?
Diarrhea
1
2018
192
0.030
 Why?
Mammary Neoplasms, Experimental
1
2017
70
0.030
 Why?
Mastectomy
1
2018
162
0.030
 Why?
Area Under Curve
1
2017
330
0.030
 Why?
Antigens, CD
1
2020
555
0.030
 Why?
Ovariectomy
1
2017
162
0.030
 Why?
Steroids
1
2017
160
0.030
 Why?
Benzamides
1
2017
224
0.030
 Why?
Cell Membrane
1
2020
706
0.030
 Why?
Nitriles
1
2017
205
0.030
 Why?
Fatigue
1
2018
366
0.030
 Why?
Flow Cytometry
2
2012
1173
0.030
 Why?
Apoptosis Regulatory Proteins
2
2009
186
0.030
 Why?
Proto-Oncogene Proteins c-mdm2
1
2015
66
0.030
 Why?
Chromatography, Liquid
1
2017
454
0.030
 Why?
Tumor Protein p73
1
2015
18
0.030
 Why?
Postmenopause
1
2017
391
0.030
 Why?
Gene Knockdown Techniques
1
2015
336
0.030
 Why?
Molecular Targeted Therapy
1
2017
432
0.030
 Why?
Transcription Factors
1
2002
1741
0.030
 Why?
Weight Gain
1
2018
556
0.030
 Why?
Serrate-Jagged Proteins
1
2014
27
0.030
 Why?
Jagged-1 Protein
1
2014
22
0.030
 Why?
Wnt-5a Protein
1
2014
24
0.030
 Why?
Argonaute Proteins
1
2014
31
0.030
 Why?
Matrix Metalloproteinase 2
1
2014
56
0.030
 Why?
Testosterone
1
2017
419
0.020
 Why?
Cell Transformation, Neoplastic
1
2015
339
0.020
 Why?
Cellular Microenvironment
1
2014
94
0.020
 Why?
Wnt Proteins
1
2014
133
0.020
 Why?
Gene Expression Regulation
1
2022
2608
0.020
 Why?
Interleukin-6
1
2017
780
0.020
 Why?
Acitretin
1
2012
3
0.020
 Why?
Guideline Adherence
1
2017
589
0.020
 Why?
Miconazole
1
2012
5
0.020
 Why?
Calcium-Binding Proteins
1
2014
219
0.020
 Why?
Socioeconomic Factors
1
2017
1326
0.020
 Why?
Isotretinoin
1
2012
26
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2014
381
0.020
 Why?
Luciferases
1
2012
152
0.020
 Why?
Genes, Reporter
1
2012
275
0.020
 Why?
Tretinoin
1
2012
124
0.020
 Why?
Biomarkers
2
2017
4271
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2014
557
0.020
 Why?
Risk Assessment
1
2020
3671
0.020
 Why?
Green Fluorescent Proteins
1
2012
405
0.020
 Why?
Proto-Oncogene Proteins
1
2014
623
0.020
 Why?
Diet
1
2018
1273
0.020
 Why?
Magnetic Resonance Imaging
2
2019
3863
0.020
 Why?
Base Sequence
1
2014
2190
0.020
 Why?
Colorado
1
2020
4564
0.020
 Why?
HEK293 Cells
1
2012
744
0.020
 Why?
Age Factors
1
2017
3333
0.020
 Why?
Hypertension
1
2018
1263
0.020
 Why?
Molecular Sequence Data
1
2014
2930
0.020
 Why?
Pregnancy Trimester, Second
1
2009
82
0.020
 Why?
Practice Guidelines as Topic
1
2017
1560
0.020
 Why?
Pregnancy Trimester, First
1
2009
136
0.020
 Why?
Lymph Node Excision
1
2009
173
0.020
 Why?
Transplantation, Heterologous
1
2008
193
0.020
 Why?
Endothelial Cells
1
2014
869
0.020
 Why?
Membrane Proteins
1
2014
1166
0.020
 Why?
Neoplasms, Experimental
1
2008
173
0.020
 Why?
CD8-Positive T-Lymphocytes
2
2002
917
0.020
 Why?
Chemokines, CXC
1
2006
68
0.010
 Why?
Nestin
1
2006
19
0.010
 Why?
Laminin
1
2006
72
0.010
 Why?
Intermediate Filament Proteins
1
2006
57
0.010
 Why?
CD4-Positive T-Lymphocytes
2
2002
1129
0.010
 Why?
Chemokine CXCL12
1
2006
89
0.010
 Why?
Infant, Newborn
2
2009
6429
0.010
 Why?
Lasers
1
2006
132
0.010
 Why?
Glial Fibrillary Acidic Protein
1
2006
124
0.010
 Why?
Drug Combinations
1
2006
390
0.010
 Why?
Adolescent
1
2024
22428
0.010
 Why?
Culture Media, Conditioned
1
2004
111
0.010
 Why?
RNA, Small Interfering
1
2006
635
0.010
 Why?
Injections, Intralesional
1
2003
36
0.010
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
54
0.010
 Why?
3T3 Cells
1
2002
156
0.010
 Why?
Random Allocation
1
2003
363
0.010
 Why?
Nerve Tissue Proteins
1
2006
592
0.010
 Why?
Models, Neurological
1
2004
254
0.010
 Why?
Adenoviridae
1
2002
199
0.010
 Why?
Reference Values
1
2003
797
0.010
 Why?
Infant, Premature
1
2006
611
0.010
 Why?
Genetic Vectors
1
2002
337
0.010
 Why?
Oligodendroglia
1
2002
187
0.010
 Why?
Transfection
1
2002
940
0.010
 Why?
Recombinant Fusion Proteins
1
2002
675
0.010
 Why?
Case-Control Studies
1
2006
3604
0.010
 Why?
Survival Rate
1
2003
2089
0.010
 Why?
Pregnancy
1
2009
7190
0.010
 Why?
Vaccination
1
2003
1423
0.010
 Why?
Prospective Studies
1
2006
7990
0.010
 Why?
Infant
1
2006
10034
0.010
 Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (428) concept(s)
_
Co-Authors Expand Description
See all (75) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)